PD Dr. med. Thomas Hundsberger
Klinik für Neurologie (50%)
Klinik für Hämatologie und medizinische Onkologie (50%)
Ko-Leitung Zentrum für seltene Erkrankungen Ostschweiz (ZSK-O)
Interdisziplinäre Neuro-onkologische Ambulanz
Dozentur Universität St. Gallen (HSG)
Themenblockkoordinator Nervensystem im Joint Medical Master UZH/HSG
Leitende(r) Arzt/Ärztin
Neurologie, Medizinische Onkologie und Hämatologie · Dept. III, Dept. I
Radiation-induced cavernoma after total body irradiation and haematopoietic stem cell transplantation in an adult patient suffering from acute myeloid leukaemia
Walch J, Tettenborn B, Weber J, Hundsberger T. Radiation-induced cavernoma after total body irradiation and haematopoietic stem cell transplantation in an adult patient suffering from acute myeloid leukaemia. Case Rep Neurol 2013; 5:91-7.
18.04.2013Radiation-induced cavernoma after total body irradiation and haematopoietic stem cell transplantation in an adult patient suffering from acute myeloid leukaemia
18.04.2013Case Rep Neurol 2013; 5:91-7
Walch Julia, Tettenborn Barbara, Weber Johannes, Hundsberger Thomas
Radiation-induced cavernoma after total body irradiation and haematopoietic stem cell transplantation in an adult patient suffering from acute myeloid leukaemia
Hundsberger T, Weber J, Tettenborn B, Walch J. Radiation-induced cavernoma after total body irradiation and haematopoietic stem cell transplantation in an adult patient suffering from acute myeloid leukaemia. Case Reports in Neurology 2013; 5:91-97.
18.04.2013Radiation-induced cavernoma after total body irradiation and haematopoietic stem cell transplantation in an adult patient suffering from acute myeloid leukaemia
18.04.2013Case Reports in Neurology 2013; 5:91-97
Hundsberger Thomas, Weber Johannes, Tettenborn Barbara, Walch Julia
Management der Von Hippel-Lindau Erkrankung
Hundsberger T. Management der Von Hippel-Lindau Erkrankung - Eine interdisziplinäre Herausforderung. info@onkologie 2013; 04:24-28.
09.02.2013Management der Von Hippel-Lindau Erkrankung
09.02.2013info@onkologie 2013; 04:24-28
Hundsberger Thomas
Re-irradiation with and without bevacizumab as salvage therapy for recurrent or progressive high-grade gliomas
Hundsberger T, Brügge D, Putora P, Weder P, Weber J, Plasswilm L. Re-irradiation with and without bevacizumab as salvage therapy for recurrent or progressive high-grade gliomas. J Neurooncol 2013; 112:133-9.
12.01.2013Re-irradiation with and without bevacizumab as salvage therapy for recurrent or progressive high-grade gliomas
12.01.2013J Neurooncol 2013; 112:133-9
Hundsberger Thomas, Brügge Detlef, Putora Paul Martin, Weder Patrik, Weber Johannes, Plasswilm Ludwig
Bevacizumab alone or in combination with irinotecan in recurrent WHO grade II and grade III gliomas
Seystahl K, Wiestler B, Hundsberger T, Happold C, Wick W, Weller M, Wick A. Bevacizumab alone or in combination with irinotecan in recurrent WHO grade II and grade III gliomas. Eur Neurol 2012; 69:95-101.
22.11.2012Bevacizumab alone or in combination with irinotecan in recurrent WHO grade II and grade III gliomas
22.11.2012Eur Neurol 2012; 69:95-101
Seystahl Katharina, Wiestler Benedikt, Hundsberger Thomas, Happold Caroline, Wick Wolfgang, Weller Michael, Wick Antje
Unilateral myokymia of the tongue – two cases, different aetiologies
Leupold D, Felbecker A, Tettenborn B, Hundsberger T (2012). Unilateral myokymia of the tongue – two cases, different aetiologies.
08.11.2012Unilateral myokymia of the tongue – two cases, different aetiologies
08.11.2012SNG Tagung
Leupold Daniela, Felbecker Ansgar, Tettenborn Barbara, Hundsberger Thomas
Case Report of a patient with LGL-Leukemia who Developed a Leptomeningeal Lymphomatosis
Schallegger K, Brügge D, Hitz F, Hundsberger T, Cathomas R, Plasswilm L (2012). Case Report of a patient with LGL-Leukemia who Developed a Leptomeningeal Lymphomatosis.
19.04.2012Case Report of a patient with LGL-Leukemia who Developed a Leptomeningeal Lymphomatosis
19.04.2012SASRO 2012
Schallegger K, Brügge Detlef, Hitz Felicitas, Hundsberger Thomas, Cathomas R, Plasswilm Ludwig
Prognostic impact of meningeal dissemination in primary CNS lymphoma (PCNSL): experience from the G-PCNSL-SG1 trial
Korfel A, Birnbaum T, Kirchen H, Mergenthaler H, Schubert J, Berdel W, Birkmann J, Hummel M, Thiel E, Leithäuser M, Hundsberger T, Weller M, Martus P, Roth P, Klasen H, Roeth A, Rauch M, Hertenstein B, Fischer T, Fischer L. Prognostic impact of meningeal dissemination in primary CNS lymphoma (PCNSL): experience from the G-PCNSL-SG1 trial. Ann Oncol 2012; 23:2374-2380.
05.03.2012Prognostic impact of meningeal dissemination in primary CNS lymphoma (PCNSL): experience from the G-PCNSL-SG1 trial
05.03.2012Ann Oncol 2012; 23:2374-2380
Korfel A, Birnbaum T, Kirchen H, Mergenthaler H-G, Schubert J, Berdel W, Birkmann J, Hummel M, Thiel E, Leithäuser M, Hundsberger Thomas, Weller M, Martus P, Roth P, Klasen H A, Roeth A, Rauch M, Hertenstein B, Fischer T, Fischer L
F-18 choline PET does not detect increased metabolism in F-18 fluoroethyltyrosine-negative low-grade gliomas
Roelcke U, Bruehlmeier M, Hefti M, Hundsberger T, Nitzsche E. F-18 choline PET does not detect increased metabolism in F-18 fluoroethyltyrosine-negative low-grade gliomas. Clin Nucl Med 2012; 37:e1-3.
26.01.2012F-18 choline PET does not detect increased metabolism in F-18 fluoroethyltyrosine-negative low-grade gliomas
26.01.2012Clin Nucl Med 2012; 37:e1-3
Roelcke Ulrich, Bruehlmeier Matthias, Hefti Martin, Hundsberger Thomas, Nitzsche Egbert U
Aktuelle Therapie des Glioblastoms
Hundsberger T. Aktuelle Therapie des Glioblastoms - Noch immer sehr schlechte Prognose. info@onkologie 2011; 06:18-20.
30.12.2011Aktuelle Therapie des Glioblastoms
30.12.2011info@onkologie 2011; 06:18-20
Hundsberger Thomas
Radiation-Induced De Novo-Cavernoma after Treatment of Acute Myeloid Leukaemia
Walch J, Weber J, Tettenborn B, Hundsberger T (2011). Radiation-Induced De Novo-Cavernoma after Treatment of Acute Myeloid Leukaemia.
08.11.2011Radiation-Induced De Novo-Cavernoma after Treatment of Acute Myeloid Leukaemia
08.11.2011186. SNG Jahrestagung, 2011
Walch J, Weber J, Tettenborn Barbara, Hundsberger Thomas
Intravascular lymphoma mimicking cerebral stroke: report of two cases
Hundsberger T, Tettenborn B, von Moos R, Fournier J, Anliker M, Gähler A, Fretz C, Kleger G, Cogliatti S, Driessen C. Intravascular lymphoma mimicking cerebral stroke: report of two cases. Case Rep Neurol 2011; 3:278-283.
24.10.2011Intravascular lymphoma mimicking cerebral stroke: report of two cases
24.10.2011Case Rep Neurol 2011; 3:278-283
Hundsberger Thomas, Tettenborn Barbara, von Moos Roger, Fournier Jean-Yves, Anliker Mark, Gähler Anita, Fretz Christian, Kleger Gian-Reto, Cogliatti Sergio B., Driessen Christoph
Evaluation of the autonomic nervous system in patients with stage IV incurable, advanced solid tumours
Hundsberger T, Vehoff J, Hägele-Link S, Tettenborn B, Strasser F (2011). Evaluation of the autonomic nervous system in patients with stage IV incurable, advanced solid tumours.
12.10.2011Evaluation of the autonomic nervous system in patients with stage IV incurable, advanced solid tumours
12.10.201113th annual meeting of the European federation of autonomic societies EFAS
Hundsberger Thomas, Vehoff Jochen, Hägele-Link Stefan, Tettenborn Barbara, Strasser F.
Akute Wernicke-Enzephalopathie im Rahmen biliär bedingter rezidivierender Pankreatitiden-ein Fallbericht
Müller-Westermann J, Traichel B, Hundsberger T, Eychmuller S, Tettenborn B (2011). Akute Wernicke-Enzephalopathie im Rahmen biliär bedingter rezidivierender Pankreatitiden-ein Fallbericht.
08.09.2011Akute Wernicke-Enzephalopathie im Rahmen biliär bedingter rezidivierender Pankreatitiden-ein Fallbericht
08.09.201184. DGN (Deutsche Gesellschaft für Neurologie) Jahreskongress, 2011
Müller-Westermann J, Traichel B, Hundsberger Thomas, Eychmuller S, Tettenborn Barbara
Die Problematik der Enzymersatztherapie beim Morbus Pompe (Glykogenose Typ II)
Hundsberger T. Die Problematik der Enzymersatztherapie beim Morbus Pompe (Glykogenose Typ II) - Eine medizinische Einschätzung. Schweiz Med Forum 2011; 11:427-429.
22.06.2011Die Problematik der Enzymersatztherapie beim Morbus Pompe (Glykogenose Typ II)
22.06.2011Schweiz Med Forum 2011; 11:427-429
Hundsberger Thomas
The evaluation of the autonomic nervous system using the Finometer Pro device and sympathetic skin response (SSR): Results in 141 consecutive patients
Vehoff J, Hägele-Link S, Hundsberger T, Tettenborn B (2011). The evaluation of the autonomic nervous system using the Finometer Pro device and sympathetic skin response (SSR): Results in 141 consecutive patients. Präsentiert bei: Jahrestagung der Schweizerischen Gesellschaft für klinische Neurophysiologie (SGKN), Luzern
20.05.2011The evaluation of the autonomic nervous system using the Finometer Pro device and sympathetic skin response (SSR): Results in 141 consecutive patients
20.05.2011Jahrestagung der Schweizerischen Gesellschaft für klinische Neurophysiologie (SGKN)
Vehoff Jochen, Hägele-Link Stefan, Hundsberger Thomas, Tettenborn Barbara
Re-Irradiation with Bevacizumab in Recurrent Malignant Gliomas
Brügge D, Putora P, Hundsberger T, Weder P, van Leyen K, Plasswilm L (2011). Re-Irradiation with Bevacizumab in Recurrent Malignant Gliomas.
31.03.2011Re-Irradiation with Bevacizumab in Recurrent Malignant Gliomas
31.03.2011SASRO 2011
Brügge Detlef, Putora Paul Martin, Hundsberger Thomas, Weder Patrik, van Leyen Karin, Plasswilm Ludwig
Brainstem tumors
Hundsberger T. Brainstem tumors. In: Brainstem disorders. 1Berlin Heidelberg: Springer-Verlag, 2010. ISBN 978-3-642--04202-7. S. 255-271.
01.01.2011Brainstem tumors
01.01.2011Springer-Verlag, ISBN 978-3-642--04202-7
Hundsberger Thomas
Koinzidenz von ischämischer Enzephalopathie und essentieller Thrombozythämie: zerebrale kortikale Venenthrombose ?
Hundsberger T, Müller S, Sommacal A, Fretz C, Tettenborn B. Koinzidenz von ischämischer Enzephalopathie und essentieller Thrombozythämie: zerebrale kortikale Venenthrombose ?. S C H W E I Z E R A R C H I V F Ü R N E U R O L O G I E U N D P S Y C H I A T R I E 2010; 161:262-265.
08.11.2010Koinzidenz von ischämischer Enzephalopathie und essentieller Thrombozythämie: zerebrale kortikale Venenthrombose ?
08.11.2010S C H W E I Z E R A R C H I V F Ü R N E U R O L O G I E U N D P S Y C H I A T R I E 2010; 161:262-265
Hundsberger Thomas, Müller Stefanie, Sommacal Andreas, Fretz Christian, Tettenborn Barbara
High-dose methotrexate with or without whole brain radiotherapy for primary CNS lymphoma (G-PCNSL-SG-1): a phase 3, randomised, non-inferiority trial
Thiel E, Birnbaum T, Fischer L, Jahnke K, Herrlinger U, Plasswilm L, Nägele T, Pietsch T, Bamberg M, Leithäuser M, Mergenthaler H, Hundsberger T, Korfel A, Martus P, Kanz L, Griesinger F, Rauch M, Röth A, Hertenstein B, von Toll T, Weller M. High-dose methotrexate with or without whole brain radiotherapy for primary CNS lymphoma (G-PCNSL-SG-1): a phase 3, randomised, non-inferiority trial. Lancet Oncol 2010; 11:1036-47.
20.10.2010High-dose methotrexate with or without whole brain radiotherapy for primary CNS lymphoma (G-PCNSL-SG-1): a phase 3, randomised, non-inferiority trial
20.10.2010Lancet Oncol 2010; 11:1036-47
Thiel Eckhard, Birnbaum Tobias, Fischer Lars, Jahnke Kristoph, Herrlinger Ulrich, Plasswilm Ludwig, Nägele Thomas, Pietsch Torsten, Bamberg Michael, Leithäuser Malte, Mergenthaler Hans-Günther, Hundsberger Thomas, Korfel Agnieszka, Martus Peter, Kanz Lothar, Griesinger Frank, Rauch Michael, Röth Alexander, Hertenstein Bernd, von Toll Theda, Weller Michael